162 related articles for article (PubMed ID: 28432514)
21. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449
[TBL] [Abstract][Full Text] [Related]
22. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011.
Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334
[TBL] [Abstract][Full Text] [Related]
23. Older women with localized breast cancer: costs and survival rates increased across two time periods.
Feinstein AJ; Long J; Soulos PR; Ma X; Herrin J; Frick KD; Chagpar AB; Krumholz HM; Yu JB; Ross JS; Gross CP
Health Aff (Millwood); 2015 Apr; 34(4):592-600. PubMed ID: 25847641
[TBL] [Abstract][Full Text] [Related]
24. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030.
Gogate A; Wheeler SB; Reeder-Hayes KE; Ekwueme DU; Fairley TL; Drier S; Trogdon JG
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34409255
[TBL] [Abstract][Full Text] [Related]
25. Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients.
Bradley CJ; Dahman B; Bear HD
Cancer; 2012 Oct; 118(20):5084-91. PubMed ID: 22415708
[TBL] [Abstract][Full Text] [Related]
26. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115).
Rosa DD; Bines J; Werutsky G; Barrios CH; Cronemberger E; Queiroz GS; de Lima VCC; Freitas-Júnior R; Couto JD; Emerenciano K; Resende H; Crocamo S; Reinert T; Van Eyil B; Nerón Y; Dybal V; Lazaretti N; de Cassia Costamilan R; de Andrade DAP; Mathias C; Vacaro GZ; Borges G; Morelle A; Caleffi M; Filho CS; Mano MS; Zaffaroni F; de Jesus RG; Simon SD
Breast Cancer Res Treat; 2020 Oct; 183(3):749-757. PubMed ID: 32728860
[TBL] [Abstract][Full Text] [Related]
27. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC
J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263
[TBL] [Abstract][Full Text] [Related]
28. Insurance status and stage of cancer at diagnosis among women with breast cancer.
Halpern MT; Bian J; Ward EM; Schrag NM; Chen AY
Cancer; 2007 Jul; 110(2):403-11. PubMed ID: 17562557
[TBL] [Abstract][Full Text] [Related]
29. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
30. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
Oestreicher N; Ramsey SD; McCune JS; Linden HM; Veenstra DL
Cancer; 2005 Nov; 104(10):2054-62. PubMed ID: 16216002
[TBL] [Abstract][Full Text] [Related]
31. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
32. A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society.
Kim HJ; Kim HJ; Lee SB; Moon HG; Noh WC; Cho YU; Yoo Y; Ahn SH;
Breast Cancer Res Treat; 2015 Aug; 153(1):153-60. PubMed ID: 26223812
[TBL] [Abstract][Full Text] [Related]
33. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.
Liedke PE; Finkelstein DM; Szymonifka J; Barrios CH; Chavarri-Guerra Y; Bines J; Vasconcelos C; Simon SD; Goss PE
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):126-33. PubMed ID: 24165578
[TBL] [Abstract][Full Text] [Related]
35. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
36. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database.
Ward EM; Fedewa SA; Cokkinides V; Virgo K
Cancer J; 2010; 16(6):614-21. PubMed ID: 21131794
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study.
Chollet-Hinton L; Anders CK; Tse CK; Bell MB; Yang YC; Carey LA; Olshan AF; Troester MA
Breast Cancer Res; 2016 Aug; 18(1):79. PubMed ID: 27492244
[TBL] [Abstract][Full Text] [Related]
38. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
39. Cost of breast cancer based on real-world data: a cancer registry study in Italy.
Capri S; Russo A
BMC Health Serv Res; 2017 Jan; 17(1):84. PubMed ID: 28122558
[TBL] [Abstract][Full Text] [Related]
40. Cost of breast cancer treatment. A 4-year longitudinal study.
Legorreta AP; Brooks RJ; Leibowitz AN; Solin LJ
Arch Intern Med; 1996 Oct; 156(19):2197-201. PubMed ID: 8885818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
